GnRHa treatment vs placebo or no pretreatment
- Preoperative medical therapy before surgery for uterine fibroids 2017 · Cochrane Headline outcomes onlyno estimate extracted5 studies · 427 participantsLow
The review found no eligible studies for this question.
The review found no eligible studies for this question.
SPRM may leads to higher preoperative bleeding: (PBAC < 75) ulipristal acetate 5 mg compared with placebo (low certainty).
SPRM may leads to higher preoperative bleeding: Reduction in menstrual bleeding (PBAC < 75)… compared with placebo (low certainty).
SPRM showed no clear difference in adverse events compared with placebo (low certainty).
The review found no eligible studies for this question.
GnRHa treatment probably leads to higher adverse events compared with placebo or no pretreatment (preoperative outcomes) (moderate certainty).
It is very uncertain whether misoprostol changes complete miscarriage compared with expectant care (very low certainty).
Misoprostol may leads to higher unplanned surgical intervention compared with surgery (low certainty).
Misoprostol showed no clear difference in women's views/acceptability of method compared with surgery (moderate certainty).
Misoprostol may leads to higher nausea compared with surgery (low certainty).
Misoprostol probably leads to higher vomiting compared with surgery (moderate certainty).
Misoprostol probably leads to higher diarrhoea compared with surgery (moderate certainty).
Misoprostol showed no clear difference in surgical evacuation compared with expectant care (low certainty).
Misoprostol showed no clear difference in unplanned surgical intervention compared with expectant care (low certainty).